↓ Skip to main content

Use of NSAIDs in treating patients with arthritis

Overview of attention for article published in Arthritis Research & Therapy, July 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)

Mentioned by

twitter
9 tweeters
facebook
2 Facebook pages
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
284 Dimensions

Readers on

mendeley
587 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Use of NSAIDs in treating patients with arthritis
Published in
Arthritis Research & Therapy, July 2013
DOI 10.1186/ar4174
Pubmed ID
Authors

Leslie J Crofford

Abstract

Patients with rheumatic diseases, including rheumatoid arthritis and osteoarthritis, almost universally describe pain and stiffness as important contributors to reduced health-related quality of life. Of the treatment options available, NSAIDs are the most widely used agents for symptomatic treatment. NSAIDs are effective anti-inflammatory and analgesic drugs by virtue of their ability to inhibit biosynthesis of prostaglandins at the level of the cyclooxygenase enzyme. However, many of the adverse effects of NSAIDs are also related to inhibition of prostaglandin production, making their use problematic in some patient populations. For the clinician, understanding the biology of prostaglandin as it relates to gastrointestinal, renal, and cardiovascular physiology and the pharmacologic properties of specific NSAIDs is key to using these drugs safely. Of particular importance is the recognition of co-morbid conditions and concomitant drugs that may increase the risk of NSAIDs in particular patients. In patients with risk factors for NSAID toxicity, using the lowest dose of a drug with a short half-life only when it is needed is likely to be the safest treatment option. For those patients whose symptoms cannot be managed with intermittent treatment, using protective strategies is essential.

Twitter Demographics

The data shown below were collected from the profiles of 9 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 587 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Portugal 1 <1%
Malaysia 1 <1%
Australia 1 <1%
India 1 <1%
Argentina 1 <1%
Spain 1 <1%
Greece 1 <1%
United States 1 <1%
Unknown 579 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 115 20%
Student > Master 90 15%
Student > Ph. D. Student 68 12%
Student > Postgraduate 53 9%
Researcher 43 7%
Other 81 14%
Unknown 137 23%
Readers by discipline Count As %
Medicine and Dentistry 114 19%
Pharmacology, Toxicology and Pharmaceutical Science 99 17%
Agricultural and Biological Sciences 56 10%
Biochemistry, Genetics and Molecular Biology 55 9%
Chemistry 22 4%
Other 83 14%
Unknown 158 27%

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 November 2021.
All research outputs
#3,029,672
of 21,666,161 outputs
Outputs from Arthritis Research & Therapy
#748
of 2,867 outputs
Outputs of similar age
#25,809
of 176,086 outputs
Outputs of similar age from Arthritis Research & Therapy
#2
of 2 outputs
Altmetric has tracked 21,666,161 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,867 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.6. This one has gotten more attention than average, scoring higher than 73% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 176,086 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one.